[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Page 33354]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09081]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0034]
Meeting of the Advisory Committee to the Director (ACD), Centers
for Disease Control and Prevention
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Advisory Committee to the Director, Centers
for Disease Control and Prevention (ACD, CDC). This meeting is open to
the public. The meeting will be webcast live via the World Wide Web.
DATES: The meeting will be held on June 6, 2024, from 10 a.m. to 3
p.m., EDT (times subject to change).
The public may submit written comments from April 29, 2024 through
May 24, 2024.
ADDRESSES: No registration is required to view the meeting via the
World Wide Web. Information for accessing the webcast will be available
at https://www.cdc.gov/about/advisory-committee-director/.
Written comments: You may submit comments identified by Docket No.
CDC-2024-0034 by either of the following methods below. Do not submit
comments for the docket by email. CDC does not accept comments for the
docket by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Tiffany Brown, JD MPH, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia
30329-4027. Attn: Docket number CDC-2024-0034.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov, suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written public comments submitted up to 72 hours prior to the ACD
meeting will be provided to ACD members before the meeting. Written
comments received in advance of the meeting will be included in the
official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Tiffany Brown, JD MPH, Centers for
Disease Control and Prevention, Office of the Chief of Staff, 1600
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027,
Telephone: (404) 498-6655; Email Address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director, CDC, shall (1)
make recommendations to the Director regarding ways to prioritize the
activities of the agency in alignment with the CDC Strategic Plan
required under section 305(c); H.R. 2617-1252; (2) advise on ways to
achieve or improve performance metrics in relation to the CDC Strategic
Plan, and other relevant metrics, as appropriate; (3) provide advice
and recommendations on the development of the Strategic Plan, and any
subsequent updates, as appropriate; (4) advise on grant, cooperative
agreements, contracts, or other transactions, as applicable; (5)
provide other advice to the Director, as requested, to fulfill duties
under sections 301 and 311; and (6) appoint subcommittees. The
committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters to be Considered: The agenda will include an update on CDC
priorities from the CDC Director, discussions on CDC's work to address
equity and social determinants of health, lab readiness and response
improvement efforts, programmatic updates, and updates from the ACD
Data and Surveillance Workgroup and the Communications and Public
Engagement Workgroup. Agenda items are subject to change as priorities
dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: The docket will be opened to receive
written comments on April 29, 2024 through May 24, 2024.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-09081 Filed 4-26-24; 8:45 am]
BILLING CODE 4163-18-P